Free Trial

Assembly Biosciences (ASMB) Earnings Date, Estimates & Call Transcripts

Assembly Biosciences logo
$14.18 +2.74 (+23.95%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$14.18 +0.00 (+0.03%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Assembly Biosciences Earnings Summary

Upcoming
Earnings Date
May. 6Before Market OpensEstimated
Consensus EPS
(Mar. 20)
-$1.75
Actual EPS
(Mar. 20)
-$1.57 Beat By $0.18
Actual Revenue
(Mar. 20)
$7.36M

Assembly Biosciences issued Q4 2024 earnings on March 20, 2025, reporting an EPS of -$1.57, which beat analysts' consensus estimates of -$1.75 by $0.18. Quarterly revenue was reported to be $7.36 million, above the consensus estimate of $7.05 million. With a trailing EPS of -$6.72, Assembly Biosciences' earnings are expected to decrease next year, from ($6.87) to ($7.64) per share.

Q4 2024 Earnings Resources

ASMB Upcoming Earnings

Assembly Biosciences' Q1 2025 earnings is scheduled for Tuesday, May 6, 2025, with a conference call scheduled on Thursday, May 8, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Assembly Biosciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Assembly Biosciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ASMB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ASMB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Assembly Biosciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$1.54-$1.54-$1.54
Q2 20251-$1.54-$1.54-$1.54
Q3 20251-$1.64-$1.64-$1.64
Q4 20251-$1.57-$1.57-$1.57

Assembly Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/6/2025
(Estimated)
--------
3/20/2025Q4 2024-$1.75-$1.57+$0.18-$1.57$7.05M$7.36M
8/8/2024Q2 2024-$2.96-$1.98+$0.98-$1.98$5.96M$8.53M
5/8/2024Q1 2024-$2.74-$1.66+$1.08-$1.66-$5.79M
11/8/2023Q3 2023-$2.76-$3.24 -$0.48-$0.27--
8/9/2023Q2 2023-$3.48-$3.84 -$0.36-$0.32--

Assembly Biosciences Earnings - Frequently Asked Questions

Assembly Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on ASMB's earnings history.

In the previous quarter, Assembly Biosciences (NASDAQ:ASMB) reported ($1.57) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.75) by $0.18. Learn more on analysts' earnings estimate vs. ASMB's actual earnings.

Assembly Biosciences (NASDAQ:ASMB) has a recorded annual revenue of $28.52 million.

Assembly Biosciences (NASDAQ:ASMB) has a recorded net income of -$61.23 million. ASMB has generated -$6.72 earnings per share over the last four quarters.

Assembly Biosciences's earnings are expected to decrease from ($6.87) per share to ($7.64) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:ASMB) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners